Safety of Cartrophen Vet in the dog: review of adverse reaction reports in the UK.

@article{Hannon2003SafetyOC,
  title={Safety of Cartrophen Vet in the dog: review of adverse reaction reports in the UK.},
  author={R. L. Hannon and J. Smith and D. Cullis-Hill and P. Ghosh and M. J. H. Cawdery},
  journal={The Journal of small animal practice},
  year={2003},
  volume={44 5},
  pages={
          202-8
        }
}
  • R. L. Hannon, J. Smith, +2 authors M. J. H. Cawdery
  • Published 2003
  • Medicine
  • The Journal of small animal practice
  • Suspected adverse reactions (SARs) reported for Cartrophen Vet (100 mg sodium pentosan polysulphate/ml) to the Veterinary Medicines Directorate in the UK for the period January 1991 to October 1999 were reviewed. Of the 161 reports, 28 were probably product related, 54 were possibly product related, 71 were unlikely to be related and eight were unclassified. An estimated real incidence of adverse reactions probably and possibly associated with Cartrophen Vet of 0.074 per cent on an individual… CONTINUE READING
    7 Citations
    Conservative Management of Hip Dysplasia.
    • T. Harper
    • Medicine
    • The Veterinary clinics of North America. Small animal practice
    • 2017
    • 5

    References

    SHOWING 1-10 OF 27 REFERENCES
    Monitoring adverse reactions to veterinary drugs. Pharmacovigilance.
    • 9
    Systemic use of pentosan polysulphate in the treatment of osteoarthritis.
    • 43
    Nonsteroidal anti-inflammatory analgesics. Indications and contraindications for pain management in dogs and cats.
    • K. Mathews
    • Medicine
    • The Veterinary clinics of North America. Small animal practice
    • 2000
    • 68
    The nature and causes of osteoarthrosis.
    • 53
    • PDF
    The treatment of osteoarthritis.
    • 28